Copyright Reports & Markets. All rights reserved.

Global Single Cell Multiomics Market Growth (Status and Outlook) 2022-2028

Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Single Cell Multiomics Market Size 2017-2028
    • 2.1.2 Single Cell Multiomics Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Single Cell Multiomics Segment by Type
    • 2.2.1 Single cell genomics
    • 2.2.2 Single cell proteomics
    • 2.2.3 Single cell transcriptomics
    • 2.2.4 Single cell metabolomics
  • 2.3 Single Cell Multiomics Market Size by Type
    • 2.3.1 Single Cell Multiomics Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Single Cell Multiomics Market Size Market Share by Type (2017-2022)
  • 2.4 Single Cell Multiomics Segment by Application
    • 2.4.1 Oncology
    • 2.4.2 Cell biology
    • 2.4.3 Neurology
    • 2.4.4 Immunology
    • 2.4.5 Stem cell research
  • 2.5 Single Cell Multiomics Market Size by Application
    • 2.5.1 Single Cell Multiomics Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Single Cell Multiomics Market Size Market Share by Application (2017-2022)

3 Single Cell Multiomics Market Size by Player

  • 3.1 Single Cell Multiomics Market Size Market Share by Players
    • 3.1.1 Global Single Cell Multiomics Revenue by Players (2020-2022)
    • 3.1.2 Global Single Cell Multiomics Revenue Market Share by Players (2020-2022)
  • 3.2 Global Single Cell Multiomics Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Single Cell Multiomics by Regions

  • 4.1 Single Cell Multiomics Market Size by Regions (2017-2022)
  • 4.2 Americas Single Cell Multiomics Market Size Growth (2017-2022)
  • 4.3 APAC Single Cell Multiomics Market Size Growth (2017-2022)
  • 4.4 Europe Single Cell Multiomics Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Single Cell Multiomics Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Single Cell Multiomics Market Size by Country (2017-2022)
  • 5.2 Americas Single Cell Multiomics Market Size by Type (2017-2022)
  • 5.3 Americas Single Cell Multiomics Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Single Cell Multiomics Market Size by Region (2017-2022)
  • 6.2 APAC Single Cell Multiomics Market Size by Type (2017-2022)
  • 6.3 APAC Single Cell Multiomics Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Single Cell Multiomics by Country (2017-2022)
  • 7.2 Europe Single Cell Multiomics Market Size by Type (2017-2022)
  • 7.3 Europe Single Cell Multiomics Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Single Cell Multiomics by Region (2017-2022)
  • 8.2 Middle East & Africa Single Cell Multiomics Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Single Cell Multiomics Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Single Cell Multiomics Market Forecast

  • 10.1 Global Single Cell Multiomics Forecast by Regions (2023-2028)
    • 10.1.1 Global Single Cell Multiomics Forecast by Regions (2023-2028)
    • 10.1.2 Americas Single Cell Multiomics Forecast
    • 10.1.3 APAC Single Cell Multiomics Forecast
    • 10.1.4 Europe Single Cell Multiomics Forecast
    • 10.1.5 Middle East & Africa Single Cell Multiomics Forecast
  • 10.2 Americas Single Cell Multiomics Forecast by Country (2023-2028)
    • 10.2.1 United States Single Cell Multiomics Market Forecast
    • 10.2.2 Canada Single Cell Multiomics Market Forecast
    • 10.2.3 Mexico Single Cell Multiomics Market Forecast
    • 10.2.4 Brazil Single Cell Multiomics Market Forecast
  • 10.3 APAC Single Cell Multiomics Forecast by Region (2023-2028)
    • 10.3.1 China Single Cell Multiomics Market Forecast
    • 10.3.2 Japan Single Cell Multiomics Market Forecast
    • 10.3.3 Korea Single Cell Multiomics Market Forecast
    • 10.3.4 Southeast Asia Single Cell Multiomics Market Forecast
    • 10.3.5 India Single Cell Multiomics Market Forecast
    • 10.3.6 Australia Single Cell Multiomics Market Forecast
  • 10.4 Europe Single Cell Multiomics Forecast by Country (2023-2028)
    • 10.4.1 Germany Single Cell Multiomics Market Forecast
    • 10.4.2 France Single Cell Multiomics Market Forecast
    • 10.4.3 UK Single Cell Multiomics Market Forecast
    • 10.4.4 Italy Single Cell Multiomics Market Forecast
    • 10.4.5 Russia Single Cell Multiomics Market Forecast
  • 10.5 Middle East & Africa Single Cell Multiomics Forecast by Region (2023-2028)
    • 10.5.1 Egypt Single Cell Multiomics Market Forecast
    • 10.5.2 South Africa Single Cell Multiomics Market Forecast
    • 10.5.3 Israel Single Cell Multiomics Market Forecast
    • 10.5.4 Turkey Single Cell Multiomics Market Forecast
    • 10.5.5 GCC Countries Single Cell Multiomics Market Forecast
  • 10.6 Global Single Cell Multiomics Forecast by Type (2023-2028)
  • 10.7 Global Single Cell Multiomics Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 10x Genomics
    • 11.1.1 10x Genomics Company Information
    • 11.1.2 10x Genomics Single Cell Multiomics Product Offered
    • 11.1.3 10x Genomics Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 10x Genomics Main Business Overview
    • 11.1.5 10x Genomics Latest Developments
  • 11.2 Becton, Dickinson and Company
    • 11.2.1 Becton, Dickinson and Company Company Information
    • 11.2.2 Becton, Dickinson and Company Single Cell Multiomics Product Offered
    • 11.2.3 Becton, Dickinson and Company Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Becton, Dickinson and Company Main Business Overview
    • 11.2.5 Becton, Dickinson and Company Latest Developments
  • 11.3 Berkeley Lights
    • 11.3.1 Berkeley Lights Company Information
    • 11.3.2 Berkeley Lights Single Cell Multiomics Product Offered
    • 11.3.3 Berkeley Lights Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Berkeley Lights Main Business Overview
    • 11.3.5 Berkeley Lights Latest Developments
  • 11.4 BGI Genomics
    • 11.4.1 BGI Genomics Company Information
    • 11.4.2 BGI Genomics Single Cell Multiomics Product Offered
    • 11.4.3 BGI Genomics Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 BGI Genomics Main Business Overview
    • 11.4.5 BGI Genomics Latest Developments
  • 11.5 Bio Rad Laboratories
    • 11.5.1 Bio Rad Laboratories Company Information
    • 11.5.2 Bio Rad Laboratories Single Cell Multiomics Product Offered
    • 11.5.3 Bio Rad Laboratories Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Bio Rad Laboratories Main Business Overview
    • 11.5.5 Bio Rad Laboratories Latest Developments
  • 11.6 Danaher Corporation (Cytiva Life Sciences)
    • 11.6.1 Danaher Corporation (Cytiva Life Sciences) Company Information
    • 11.6.2 Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Product Offered
    • 11.6.3 Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Danaher Corporation (Cytiva Life Sciences) Main Business Overview
    • 11.6.5 Danaher Corporation (Cytiva Life Sciences) Latest Developments
  • 11.7 Dolomite Bio
    • 11.7.1 Dolomite Bio Company Information
    • 11.7.2 Dolomite Bio Single Cell Multiomics Product Offered
    • 11.7.3 Dolomite Bio Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Dolomite Bio Main Business Overview
    • 11.7.5 Dolomite Bio Latest Developments
  • 11.8 Epicypher
    • 11.8.1 Epicypher Company Information
    • 11.8.2 Epicypher Single Cell Multiomics Product Offered
    • 11.8.3 Epicypher Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Epicypher Main Business Overview
    • 11.8.5 Epicypher Latest Developments
  • 11.9 Fluidigm Corporation
    • 11.9.1 Fluidigm Corporation Company Information
    • 11.9.2 Fluidigm Corporation Single Cell Multiomics Product Offered
    • 11.9.3 Fluidigm Corporation Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Fluidigm Corporation Main Business Overview
    • 11.9.5 Fluidigm Corporation Latest Developments
  • 11.10 Illimina
    • 11.10.1 Illimina Company Information
    • 11.10.2 Illimina Single Cell Multiomics Product Offered
    • 11.10.3 Illimina Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Illimina Main Business Overview
    • 11.10.5 Illimina Latest Developments
  • 11.11 Miltenyi Biotec B.V. & CO.
    • 11.11.1 Miltenyi Biotec B.V. & CO. Company Information
    • 11.11.2 Miltenyi Biotec B.V. & CO. Single Cell Multiomics Product Offered
    • 11.11.3 Miltenyi Biotec B.V. & CO. Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Miltenyi Biotec B.V. & CO. Main Business Overview
    • 11.11.5 Miltenyi Biotec B.V. & CO. Latest Developments
  • 11.12 Mission Bio
    • 11.12.1 Mission Bio Company Information
    • 11.12.2 Mission Bio Single Cell Multiomics Product Offered
    • 11.12.3 Mission Bio Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Mission Bio Main Business Overview
    • 11.12.5 Mission Bio Latest Developments
  • 11.13 Nanostring Technologies
    • 11.13.1 Nanostring Technologies Company Information
    • 11.13.2 Nanostring Technologies Single Cell Multiomics Product Offered
    • 11.13.3 Nanostring Technologies Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Nanostring Technologies Main Business Overview
    • 11.13.5 Nanostring Technologies Latest Developments
  • 11.14 Olink Holding AB (Olink Proteomics)
    • 11.14.1 Olink Holding AB (Olink Proteomics) Company Information
    • 11.14.2 Olink Holding AB (Olink Proteomics) Single Cell Multiomics Product Offered
    • 11.14.3 Olink Holding AB (Olink Proteomics) Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Olink Holding AB (Olink Proteomics) Main Business Overview
    • 11.14.5 Olink Holding AB (Olink Proteomics) Latest Developments
  • 11.15 Parse Bioscience
    • 11.15.1 Parse Bioscience Company Information
    • 11.15.2 Parse Bioscience Single Cell Multiomics Product Offered
    • 11.15.3 Parse Bioscience Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Parse Bioscience Main Business Overview
    • 11.15.5 Parse Bioscience Latest Developments
  • 11.16 Qiagen N.V.
    • 11.16.1 Qiagen N.V. Company Information
    • 11.16.2 Qiagen N.V. Single Cell Multiomics Product Offered
    • 11.16.3 Qiagen N.V. Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Qiagen N.V. Main Business Overview
    • 11.16.5 Qiagen N.V. Latest Developments
  • 11.17 Takara Holdings Inc. Takara Bio Group
    • 11.17.1 Takara Holdings Inc. Takara Bio Group Company Information
    • 11.17.2 Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Product Offered
    • 11.17.3 Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 Takara Holdings Inc. Takara Bio Group Main Business Overview
    • 11.17.5 Takara Holdings Inc. Takara Bio Group Latest Developments
  • 11.18 Thermo Fisher Scientific
    • 11.18.1 Thermo Fisher Scientific Company Information
    • 11.18.2 Thermo Fisher Scientific Single Cell Multiomics Product Offered
    • 11.18.3 Thermo Fisher Scientific Single Cell Multiomics Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 Thermo Fisher Scientific Main Business Overview
    • 11.18.5 Thermo Fisher Scientific Latest Developments

12 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Single Cell Multiomics will have significant change from previous year. According to our (LP Information) latest study, the global Single Cell Multiomics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Single Cell Multiomics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Single Cell Multiomics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Single Cell Multiomics market, reaching US$ million by the year 2028. As for the Europe Single Cell Multiomics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Single Cell Multiomics players cover 10x Genomics, Becton, Dickinson and Company, Berkeley Lights, and BGI Genomics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Single Cell Multiomics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

by Type
Single cell genomics
Single cell proteomics
Single cell transcriptomics
Single cell metabolomics
by Technique
Single cell isolation and dispensing
Single cell analysis

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Oncology
Cell biology
Neurology
Immunology
Stem cell research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

10x Genomics
Becton, Dickinson and Company
Berkeley Lights
BGI Genomics
Bio Rad Laboratories
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Epicypher
Fluidigm Corporation
Illimina
Miltenyi Biotec B.V. & CO.
Mission Bio
Nanostring Technologies
Olink Holding AB (Olink Proteomics)
Parse Bioscience
Qiagen N.V.
Takara Holdings Inc. Takara Bio Group
Thermo Fisher Scientific

Buy now